drugset / Trial / NCT04853901
Remdesivir Efficacy In Management Of COVID-19 Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is open label randomized interventional phase 3 clinical trial. Patients with confirmed Covid-19 cases who was hospitalized in Two university isolation hospitals (Ain Shams University and Assiut University ) assigned hospitals for isolation.
Timeline
- Start
- 2020-07-27
- Primary completion
- 2021-01-01
- Completion
- 2021-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydroxycoloroquine | Unknown | 200 mg | — |
| Subject | Remdesivir | Small molecule | 100 mg | Intravenous |
| Comparator | Methylprednisolone | Other / unclassified | 1 mg/kg | — |
| Comparator | Methylprednisolone | Other / unclassified | 2 mg/kg | — |